|
|
||||||||
causes reversible in vivo systemic vascular barrier
dysfunction via NO-dependent and -independent
mechanisms
Departments of 1 Surgery and
2 Pathology,
Tumor necrosis factor (TNF-
) and nitric
oxide (NO) are important vasoactive mediators of septic shock. This
study used a well-characterized quantitative permeation method to
examine the effect of TNF-
and NO on systemic vascular barrier
function in vivo, without confounding endotoxemia, hypotension, or
organ damage. Our results showed 1)
TNF-
reversibly increased albumin permeation in the systemic
vasculature (e.g., lung, liver, brain, etc.); 2) TNF-
did not affect
hemodynamics or blood flow or cause significant tissue injury;
3) pulmonary vascular barrier
dysfunction was associated with increased lung water content and
impaired oxygenation; 4) TNF-
caused inducible nitric oxide synthase (iNOS) mRNA expression in the
lung and increased in vivo NO production;
5) selective inhibition of iNOS with
aminoguanidine prevented TNF-
-induced lung and liver vascular
barrier dysfunction; 6)
aminoguanidine prevented increased tissue water content in
TNF-
-treated lungs and improved oxygenation; and
7) nonselective inhibition of NOS with NG-monomethly-L-arginine
increased vascular permeation in control lungs and caused severe lung
injury in TNF-
-treated animals. We conclude that
1) TNF-
reversibly impairs
vascular barrier integrity through NO-dependent and -independent
mechanisms; 2) nonselective NOS
inhibition increased vascular barrier dysfunction and caused severe
lung injury, whereas selective inhibition of iNOS prevented impaired
endothelial barrier integrity and pulmonary dysfunction; and
3) selective inhibition of iNOS may
be beneficial in treating increased vascular permeability that
complicates endotoxemia and cytokine immunotherapy.
blood-brain barrier; capillary permeability; cytokines; endothelium; lung; nitric oxide
This article has been cited by other articles:
![]() |
M. Westerberg, J. Gabel, A. Bengtsson, J. Sellgren, O. Eidem, and A. Jeppsson Hemodynamic effects of cardiotomy suction blood J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1352 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Matsuda, Y. Hattori, Y. Takahashi, J. Nishihira, S. Jesmin, M. Kobayashi, and S. Gando Therapeutic effect of in vivo transfection of transcription factor decoy to NF-{kappa}B on septic lung in mice Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1248 - L1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Heckel, R. Kiefmann, M. Dorger, M. Stoeckelhuber, and A. E. Goetz Colloidal gold particles as a new in vivo marker of early acute lung injury Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L867 - L878. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Paparella, T.M. Yau, and E. Young Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 232 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. M. Dias, A. R. Goodman, J. L. Dos Santos, R. N. Gomes, A. Altmeyer, P. T. Bozza, M. de Fatima Horta, J. Vilcek, and L. F. L. Reis TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis J. Leukoc. Biol., June 1, 2001; 69(6): 928 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schwenk, A. Beisenherz, K. Romer, G. Kremer, B. Salzberger, and M. Elia Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment Am. J. Clinical Nutrition, August 1, 2000; 72(2): 496 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kamochi, F. Kamochi, Y. B. Kim, S. Sawh, J. M. Sanders, I. Sarembock, S. Green, J. S. Young, K. Ley, S. M. Fu, et al. P-selectin and ICAM-1 mediate endotoxin-induced neutrophil recruitment and injury to the lung and liver Am J Physiol Lung Cell Mol Physiol, August 1, 1999; 277(2): L310 - L319. [Abstract] [Full Text] [PDF] |
||||
![]() |
D R Thickett, L Armstrong, and A B Millar Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions Thorax, August 1, 1999; 54(8): 707 - 710. [Abstract] [Full Text] |
||||
![]() |
G. J. T. Horst Letters to the Editor Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1910 - H1911. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |